الصفحة الرئيسية>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Nalidixic acid

Nalidixic acid (Synonyms: NSC 82174, WIN 18,320)

رقم الكتالوجGC12455

حمض الناليديكسيك ، مضاد حيوي من الكينولون ، فعال ضد البكتيريا موجبة الجرام وسالبة الجرام

Products are for research use only. Not for human use. We do not sell to patients.

Nalidixic acid التركيب الكيميائي

Cas No.: 389-08-2

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
35٫00
متوفر
50mg
48٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Nalidixic acid is a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum.Target: AntibacterialNalidixic acid is the first of the synthetic quinolone antibiotics. Nalidixic acid is effective against both gram-positive and gram-negative bacteria. In lower concentrations, it acts in a bacteriostatic manner; that is, it inhibits growth and reproduction. In higher concentrations, it is bactericidal, meaning that it kills bacteria instead of merely inhibiting their growth. Nalidixic selectively and reversibly blocks DNA replication in susceptible bacteria. Nalidixic acid and related antibiotics inhibit a subunit of DNA gyrase and topoisomerase IV and induce formation of cleavage complexes. It also inhibits the nicking-closing activity on the subunit of DNA gyrase that releases the positive binding stress on the supercoiled DNA. From Wikipedia.

References:
[1]. http://en.wikipedia.org/wiki/Nalidixic_acid

مراجعات

Review for Nalidixic acid

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Nalidixic acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.